9267 — Genky Drugstores Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMid CapHigh Flyer

Annual income statement for Genky Drugstores Co, fiscal year end - June 20th, JPY millions except per share, conversion factor applied.

	2021 June 20th	2022 June 20th	2023 June 20th	2024 June 20th	2025 June 20th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	142,376	154,640	169,059	184,860	200,786
Cost of Revenue
Gross Profit	30,289	30,954	34,554	37,621	40,890
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	136,020	148,969	162,735	176,296	191,129
Operating Profit	6,356	5,670	6,324	8,564	9,657
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6,663	6,084	6,704	8,803	9,902
Provision for Income Taxes
Net Income After Taxes	4,832	4,421	4,765	6,325	7,066
Net Income Before Extraordinary Items
Net Income	4,832	4,421	4,765	6,325	7,066
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,832	4,421	4,764	6,324	7,066
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	158	146	166	219	232
Dividends per Share